• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vax-Plasma in Patients With Refractory COVID-19.

作者信息

Ordaya Eloy E, Abu Saleh Omar M, Stubbs James R, Joyner Michael J

机构信息

Mayo Clinic, Rochester, MN.

出版信息

Mayo Clin Proc. 2022 Jan;97(1):186-189. doi: 10.1016/j.mayocp.2021.11.001. Epub 2021 Nov 12.

DOI:10.1016/j.mayocp.2021.11.001
PMID:34996552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8585589/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c9/8585589/52d990c4fd96/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c9/8585589/52d990c4fd96/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c9/8585589/52d990c4fd96/gr1_lrg.jpg

相似文献

1
Vax-Plasma in Patients With Refractory COVID-19.难治性新冠肺炎患者的疫苗接种血浆治疗
Mayo Clin Proc. 2022 Jan;97(1):186-189. doi: 10.1016/j.mayocp.2021.11.001. Epub 2021 Nov 12.
2
Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire!新冠康复期血浆治疗后的肺血栓栓塞：火上浇油！
Adv Respir Med. 2021;89(3):347-349. doi: 10.5603/ARM.a2021.0022. Epub 2021 Apr 21.
3
Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review.妊娠合并2019冠状病毒病的康复期血浆治疗：一例病例报告及文献复习
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100174. doi: 10.1016/j.ajogmf.2020.100174. Epub 2020 Jul 3.
4
Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response.慢性淋巴细胞白血病患者长期新冠病毒肺炎的恢复期血浆和瑞德西韦治疗：快速初始反应后晚期复发的病例报告
Br J Haematol. 2022 Feb;196(3):e27-e29. doi: 10.1111/bjh.17806. Epub 2021 Aug 30.
5
The FDA and the Importance of Trust.美国食品药品监督管理局与信任的重要性。
N Engl J Med. 2020 Dec 31;383(27):e148. doi: 10.1056/NEJMe2030687. Epub 2020 Sep 30.
6
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.瑞德西韦与高滴度康复期血浆联合用于COVID-19感染血液病患者的早期治疗取得成功。
Hematol Oncol. 2021 Dec;39(5):715-720. doi: 10.1002/hon.2908. Epub 2021 Aug 16.
7
WHO covid-19 drugs guideline: reconsider using convalescent plasma.世界卫生组织新冠病毒病药物指南：重新考虑使用康复期血浆。
BMJ. 2022 Feb 8;376:o295. doi: 10.1136/bmj.o295.
8
Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma.新冠康复者血浆在一名近期接受滤泡性淋巴瘤治疗的患者中的成功应用。
Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):66-68. doi: 10.1016/j.clml.2020.06.012. Epub 2020 Jun 25.
9
The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19.来自康复期血浆的浓缩抗体平衡了重症 COVID-19 患者功能失调的免疫反应。
Clin Transl Med. 2021 Nov;11(11):e571. doi: 10.1002/ctm2.571.
10
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.用于治疗新冠病毒肺炎的康复期血浆——解读其中的不一致之处
N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.

引用本文的文献

1
Exercise and Experiments of Nature.《自然的锻炼与实验》
Compr Physiol. 2023 Jun 26;13(3):4879-4907. doi: 10.1002/cphy.c220027.
2
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.关于使用恢复期血浆治疗 2019 冠状病毒病免疫功能低下患者的指南。
Clin Infect Dis. 2023 Jun 8;76(11):2018-2024. doi: 10.1093/cid/ciad066.
3
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.COVID-19 恢复期血浆治疗免疫功能低下患者：系统评价和荟萃分析。

本文引用的文献

1
Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews.新冠康复期血浆疗法的安全性与有效性：系统评价综述
Diagnostics (Basel). 2021 Sep 11;11(9):1663. doi: 10.3390/diagnostics11091663.
2
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.SARS-CoV-2 多克隆中和抗体逃逸的高遗传屏障。
Nature. 2021 Dec;600(7889):512-516. doi: 10.1038/s41586-021-04005-0. Epub 2021 Sep 20.
3
Use of convalescent plasma in COVID-19 patients with immunosuppression.COVID-19 免疫抑制患者使用恢复期血浆。
JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647.
4
Antibodies as drugs-a Keystone Symposia report.抗体类药物——一个 Keystone 研讨会报告
Ann N Y Acad Sci. 2023 Jan;1519(1):153-166. doi: 10.1111/nyas.14915. Epub 2022 Nov 16.
5
Commentary on "Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study".关于“恢复期血浆中针对 SARS-CoV-2 的高与低中和抗体滴度对住院患者的影响的评论：冠状病毒灭活血浆（CoVIP）研究”。
mBio. 2022 Dec 20;13(6):e0265322. doi: 10.1128/mbio.02653-22. Epub 2022 Oct 31.
6
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19.免疫抑制的新冠肺炎患者的疫苗增强恢复期血浆疗法。
Blood Adv. 2022 Dec 13;6(23):5951-5955. doi: 10.1182/bloodadvances.2022008932.
7
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients.关注变异株-血清阴性住院患者使用匹配的 COVID-19 恢复期血浆。
Viruses. 2022 Jun 30;14(7):1443. doi: 10.3390/v14071443.
Transfusion. 2021 Aug;61(8):2503-2511. doi: 10.1111/trf.16525. Epub 2021 Jun 1.
4
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.恢复期血浆疗法对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Mayo Clin Proc. 2021 May;96(5):1262-1275. doi: 10.1016/j.mayocp.2021.02.008. Epub 2021 Feb 17.
5
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.mRNA疫苗接种可增强由SARS-CoV-2感染引发的交叉变异中和抗体。
Science. 2021 Mar 25;372(6549):1413-8. doi: 10.1126/science.abg9175.
6
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.COVID-19 病程延长的 B 细胞耗竭患者的恢复期血浆治疗。
Blood. 2020 Nov 12;136(20):2290-2295. doi: 10.1182/blood.2020008423.
7
Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature.利妥昔单抗治疗后持续的 SARS-CoV-2 血症：两例致命病例及文献复习。
Br J Haematol. 2020 Jul;190(2):185-188. doi: 10.1111/bjh.16896. Epub 2020 Jun 22.
8
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.恢复期血浆和高效免疫球蛋白治疗病毒性病因严重急性呼吸道感染的有效性：系统评价与探索性Meta分析
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.